284 related articles for article (PubMed ID: 16130843)
41. Cervical, endometrial and ovarian cancers among immigrants in Sweden: importance of age at migration and duration of residence.
Beiki O; Allebeck P; Nordqvist T; Moradi T
Eur J Cancer; 2009 Jan; 45(1):107-18. PubMed ID: 18829301
[TBL] [Abstract][Full Text] [Related]
42. Factors associated with enrollment in cancer genetics research.
Ford BM; Evans JS; Stoffel EM; Balmaña J; Regan MM; Syngal S
Cancer Epidemiol Biomarkers Prev; 2006 Jul; 15(7):1355-9. PubMed ID: 16835336
[TBL] [Abstract][Full Text] [Related]
43. Treatment effects, disease recurrence, and survival in obese women with early endometrial carcinoma : a Gynecologic Oncology Group study.
von Gruenigen VE; Tian C; Frasure H; Waggoner S; Keys H; Barakat RR
Cancer; 2006 Dec; 107(12):2786-91. PubMed ID: 17096437
[TBL] [Abstract][Full Text] [Related]
44. Clinical analysis of synchronous primary neoplasms of the female reproductive tract.
Tong SY; Lee YS; Park JS; Bae SN; Lee JM; Namkoong SE
Eur J Obstet Gynecol Reprod Biol; 2008 Jan; 136(1):78-82. PubMed ID: 17049712
[TBL] [Abstract][Full Text] [Related]
45. Enrollment of elderly patients in clinical trials for cancer drug registration: a 7-year experience by the US Food and Drug Administration.
Talarico L; Chen G; Pazdur R
J Clin Oncol; 2004 Nov; 22(22):4626-31. PubMed ID: 15542812
[TBL] [Abstract][Full Text] [Related]
46. Quality of life of women with gynecologic cancer: associated factors.
Vaz AF; Pinto-Neto AM; Conde DM; Costa-Paiva L; Morais SS; Esteves SB
Arch Gynecol Obstet; 2007 Dec; 276(6):583-9. PubMed ID: 17564721
[TBL] [Abstract][Full Text] [Related]
47. Measurement of factors influencing the participation of patients with prostate cancer in clinical trials: a Canadian perspective.
Davison BJ; So A; Goldenberg SL; Berkowitz J; Gleave ME
BJU Int; 2008 Apr; 101(8):982-7. PubMed ID: 18005198
[TBL] [Abstract][Full Text] [Related]
48. Patient entry into randomized controlled trials of colorectal cancer treatment: factors influencing participation.
Solomon MJ; Pager CK; Young JM; Roberts R; Butow P
Surgery; 2003 Jun; 133(6):608-13. PubMed ID: 12796726
[TBL] [Abstract][Full Text] [Related]
49. Organizational barriers to physician participation in cancer clinical trials.
Somkin CP; Altschuler A; Ackerson L; Geiger AM; Greene SM; Mouchawar J; Holup J; Fehrenbacher L; Nelson A; Glass A; Polikoff J; Tishler S; Schmidt C; Field T; Wagner E
Am J Manag Care; 2005 Jul; 11(7):413-21. PubMed ID: 16044978
[TBL] [Abstract][Full Text] [Related]
50. Enrollment of older patients in cancer treatment trials in Canada: why is age a barrier?
Yee KW; Pater JL; Pho L; Zee B; Siu LL
J Clin Oncol; 2003 Apr; 21(8):1618-23. PubMed ID: 12697888
[TBL] [Abstract][Full Text] [Related]
51. Effect of statin on risk of gynecologic cancers: a meta-analysis of observational studies and randomized controlled trials.
Liu Y; Qin A; Li T; Qin X; Li S
Gynecol Oncol; 2014 Jun; 133(3):647-55. PubMed ID: 24736024
[TBL] [Abstract][Full Text] [Related]
52. New treatment concepts for gynecologic pelvic malignancies: neoadjuvant therapies.
Restivo A; Gordinier M; Granai CO
Surg Oncol Clin N Am; 2005 Apr; 14(2):239-47. PubMed ID: 15817237
[No Abstract] [Full Text] [Related]
53. A multicenter evaluation of sequential multimodality therapy and clinical outcome for the treatment of advanced endometrial cancer.
Secord AA; Havrilesky LJ; O'Malley DM; Bae-Jump V; Fleming ND; Broadwater G; Cohn DE; Gehrig PA
Gynecol Oncol; 2009 Sep; 114(3):442-7. PubMed ID: 19560193
[TBL] [Abstract][Full Text] [Related]
54. Laparoscopy and gynecologic oncology.
Cho JE; Liu C; Gossner G; Nezhat FR
Clin Obstet Gynecol; 2009 Sep; 52(3):313-26. PubMed ID: 19661747
[TBL] [Abstract][Full Text] [Related]
55. Understanding the decisions of cancer clinical trial participants to enter research studies: factors associated with informed consent, patient satisfaction, and decisional regret.
Stryker JE; Wray RJ; Emmons KM; Winer E; Demetri G
Patient Educ Couns; 2006 Oct; 63(1-2):104-9. PubMed ID: 16242898
[TBL] [Abstract][Full Text] [Related]
56. Colorectal stents for palliation of large-bowel obstructions in recurrent gynecologic cancer: an updated series.
Caceres A; Zhou Q; Iasonos A; Gerdes H; Chi DS; Barakat RR
Gynecol Oncol; 2008 Mar; 108(3):482-5. PubMed ID: 18190953
[TBL] [Abstract][Full Text] [Related]
57. Role of appendectomy at the time of primary surgery in patients with early-stage ovarian cancer.
Ramirez PT; Slomovitz BM; McQuinn L; Levenback C; Coleman RL
Gynecol Oncol; 2006 Dec; 103(3):888-90. PubMed ID: 16806436
[TBL] [Abstract][Full Text] [Related]
58. Predictors for long-term survival after interdisciplinary salvage surgery for advanced or recurrent gynecologic cancers.
Fleisch MC; Pantke P; Beckmann MW; Schnuerch HG; Ackermann R; Grimm MO; Bender HG; Dall P
J Surg Oncol; 2007 May; 95(6):476-84. PubMed ID: 17192947
[TBL] [Abstract][Full Text] [Related]
59. Who refuses enrollment in cardiac clinical trials?
Sen Biswas M; Newby LK; Bastian LA; Peterson ED; Sugarman J
Clin Trials; 2007; 4(3):258-63. PubMed ID: 17715252
[TBL] [Abstract][Full Text] [Related]
60. Different rates of clinical trial enrollment between adolescents and young adults aged 15 to 22 years old and children under 15 years old with cancer at a children's hospital.
Shaw PH; Ritchey AK
J Pediatr Hematol Oncol; 2007 Dec; 29(12):811-4. PubMed ID: 18090927
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
